Advertisement

Topics

Bristol-Myers Says FDA Expands Approval Of Sprycel

07:02 EST 10 Nov 2017 | FinanzNachrichten

NEW YORK CITY (dpa-AFX) - Bristol-Myers Squibb Co. (BMY) announced the U.S. Food and Drug Administration (FDA) has expanded the indication for Sprycel or dasatinib tablets to include the treatment...

Original Article: Bristol-Myers Says FDA Expands Approval Of Sprycel

NEXT ARTICLE

More From BioPortfolio on "Bristol-Myers Says FDA Expands Approval Of Sprycel"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...